230 related articles for article (PubMed ID: 7729466)
1. Glycopeptides in the treatment of staphylococcal infections.
Daschner FD; Kropec A
Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
[TBL] [Abstract][Full Text] [Related]
2. [Recent trend and development of novel antimicrobial agents for MRSA infections].
Nishino T
Nihon Rinsho; 1992 May; 50(5):1066-74. PubMed ID: 1324332
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of teicoplanin as antimicrobial treatment of severe nosocomial infections caused by gram-positive bacteria: a preliminary study.
Micozzi A; Venditti M; Brandimarte C; Baiocchi P; Martino P; Serra P
Chemioterapia; 1988 Apr; 7(2):101-4. PubMed ID: 2969302
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant staphylococci.
Thornsberry C
Clin Lab Med; 1989 Jun; 9(2):255-67. PubMed ID: 2659244
[TBL] [Abstract][Full Text] [Related]
5. Recognition and importance of Staphylococcus epidermidis infections.
Blum RA; Rodvold KA
Clin Pharm; 1987 Jun; 6(6):464-75. PubMed ID: 3319361
[TBL] [Abstract][Full Text] [Related]
6. [Infections caused by staphylococci. The human as a source of infection for S. aureus and coagulase negative staphylococci].
Peters G
Fortschr Med; 1991 Jul; 109(22):437-40. PubMed ID: 1937322
[TBL] [Abstract][Full Text] [Related]
7. Coagulase-negative staphylococci. Epidemiology, evaluation, and therapy.
Nafziger DA; Wenzel RP
Infect Dis Clin North Am; 1989 Dec; 3(4):915-29. PubMed ID: 2687369
[TBL] [Abstract][Full Text] [Related]
8. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
Webster A; Wilson AP; Treasure T; Grüneberg RN
Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic considerations for infections caused by Staphylococcus epidermidis.
Rodvold KA
Pharmacotherapy; 1988; 8(6 Pt 2):14S-18S. PubMed ID: 3075743
[TBL] [Abstract][Full Text] [Related]
11. Therapy of serious gram-positive infections with teicoplanin.
Davies AJ; Stone JM; Synott M
Drugs Exp Clin Res; 1989; 15(1):29-31. PubMed ID: 2526010
[TBL] [Abstract][Full Text] [Related]
12. [Coagulase-negative staphylococcal infections].
Kobayashi H
Nihon Rinsho; 1992 Nov; 50(11):2765-72. PubMed ID: 1287251
[TBL] [Abstract][Full Text] [Related]
13. [Nosocomial Staphylococcus epidermidis and Staphylococcus aureus septicemias in neonates].
Gouyon JB; François C; Semama D; Sandre D; Duez JM; Portier H
Ann Pediatr (Paris); 1990 Jan; 37(1):21-5. PubMed ID: 2316958
[TBL] [Abstract][Full Text] [Related]
14. Solid-phase radioimmunoassay for IgG antibodies to Staphylococcus epidermidis. Use in serious coagulase-negative staphylococcal infections.
Espersen F; Wheat LJ; Bemis AT; White A; Bayer AS; Hooper DC
Arch Intern Med; 1987 Apr; 147(4):689-93. PubMed ID: 3103563
[TBL] [Abstract][Full Text] [Related]
15. Coagulase-negative staphylococcal infections.
Valadez JA; Boldrick RW; Dixon CL
Compr Ther; 1988 Mar; 14(3):14-8. PubMed ID: 3282764
[No Abstract] [Full Text] [Related]
16. Open study of teicoplanin in gram-positive infections.
Walsh B; Drabu YJ; Mehtar S; Blakemore PH
Int J Clin Pharmacol Res; 1988; 8(2):99-100. PubMed ID: 2967801
[TBL] [Abstract][Full Text] [Related]
17. Current problems of chemotherapy of infections with coagulase-negative staphylococci.
Davies AJ; Stone JW
Eur J Clin Microbiol; 1986 Jun; 5(3):277-81. PubMed ID: 3527698
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
Davey PG; Williams AH
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
[TBL] [Abstract][Full Text] [Related]
19. [Microbiological-clinical study on the efficacy of a new antibiotic: teicoplanin].
Martinetto P; Gariglio M; Malcangi A; Cavallo GP
G Batteriol Virol Immunol; 1985; 78(1-6):86-94. PubMed ID: 2943627
[TBL] [Abstract][Full Text] [Related]
20. [Primary and secondary neonatal negative coagulase staphylococcus infections].
Aujard Y; Baumann C; Bloch J; Gagliardone C; Bingen E
Rev Prat; 1991 May; 41(15):1363-7. PubMed ID: 2063135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
